Cuba’s homegrown Covid-19 vaccines advance into late-stage trials
In a bold move to reboot the nation’s economy and vaccinate the population, Cuba is close to signing off its…
In a bold move to reboot the nation’s economy and vaccinate the population, Cuba is close to signing off its…
9 December Globally, the total confirmed cases of Covid-19 have reached over 68,367,000, with over 1,559,000 deaths and 44,095,000 recoveries.…
Eli Lilly and Company and Incyte have reported positive top-line results from Phase III BRAVE-AA2 study of baricitinib, which demonstrated hair regrowth in adults with…
Vir Biotechnology and GlaxoSmithKline (GSK) have reported that an independent Data and Safety Monitoring Board (DSMB) has recommended halting enrolment in the VIR-7831 (GSK4182136) arm…
Amgen has reported positive data from the Phase III study of BLINCYTO (blinatumomab) in paediatric patients with high-risk first-relapse B-cell…
On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the treatment of patients with metastatic…
Science 37 has collaborated with digital health and telemedicine company Medgate to further globalise decentralised clinical trials. With presence in…
ObvioHealth is set to initiate a Phase II/III study of RedHill Biopharma’s RHB-107 (upamostat) in the US for Covid-19 treatment.…
8 September Global: The global coronavirus death toll has passed another sombre milestone, exceeding 892,000 as confirmed by researchers at…
8 September Globally, the total confirmed cases of Covid-19 have reached over 27,342,000, with over 892,000 deaths and 18,338,000 recoveries.…
COSELA™ (trilaciclib) is the first approved myeloprotection therapy indicated to reduce the occurrence of chemotherapy-induced bone marrow suppression in adult…
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…